CFDA releases clinical trial guidance

In broad, newly released guidelines for conducting clinical trials, China FDA outlined best practices for designing and conducting Phase I-IV studies. The agency said the document should provide technical guidance to researchers and application sponsors to develop R&D strategies. The guidelines outlined objectives for each stage of clinical development, emphasizing the importance of patient safety and obtaining reliable scientific results...